Work

Phase 1 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-126009

Authors: Colin D. Godwin, Megan Othus, Mary-Elizabeth M. Percival, Bart L. Scott, Pamela S. Becker, Kelda M. Gardner, Sioban B. Keel, Tejaswini M. Dhawale, Vivian G. Oehler, Janis L. Abkowitz, Anna B. Halpern, Paul C. Hendrie, Kaysey F. Orlowski, Alice Woo, Elihu H. Estey, Roland B. Walter

Institutions: University of Washington, Fred Hutch Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2986869002

Cites:

Cited by: 1

Related to: 10